Target intelligence / Profile preview

Hepatoprotection

Molecular classification
Other
01

Overview

Hepatoprotection refers broadly to the prevention or reduction of liver damage by chemical substances. This property can be attributed to various natural products and synthetic drugs that act through diverse mechanisms such as antioxidant activity, inhibition of inflammatory pathways in hepatic cells like Kupffer cells, enhancement of detoxification processes, and support for hepatic regeneration. The term does not denote any single molecule or receptor but instead describes an important therapeutic goal in treating conditions involving acute or chronic liver injury due to toxins, infections, metabolic disorders, or drug overdose. Well-known examples include acetylcysteine for paracetamol poisoning and silymarin from Milk Thistle for various toxic insults; numerous herbs are also studied for their potential protective effects on the liver[1][3][4]. “Hepatoprotection...is the ability...to prevent damage to the liver.... An example...is silibinin...which selectively inhibits leukotriene formation by Kupffer cells.” [1] “Hepatoprotection refers to the act of protecting essential functions of the liver....” [5] In summary: “Hepatoprotection” is an outcome/therapeutic property—not a canonical drug target—so structured information about receptors/molecules cannot be provided under this name.

Other names
hepatoprotective effectantihepatotoxicity
02

Mechanism of action

Mechanisms depend on the agent and may include: Antioxidant activity, Inhibition of inflammatory mediators/leukotriene formation by Kupffer cells, Enhancement of hepatic regeneration and repair processes.

03

Biological functions

Prevention of liver damageProtection of hepatic functionAntioxidant activityAnti-inflammatory effects
04

Disease associations

Liver diseasesHepatitisCirrhosisDrug-induced liver injury
05

Safety considerations

Safety concerns pertain to individual drugs with purported hepatoprotective effectsSome herbal remedies may have their own toxicity profiles
06

Interacting drugs

Acetylcysteine

5 more in the full profile.

07

Biomarkers

Alanine transaminase (ALT)Aspartate transaminase (AST)Alkaline phosphatase

Beyond the preview

Go deeper on Hepatoprotection.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hepatoprotection.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call